Clinical trial
Study of Two Single Nucleotide Polymorphisms in Chinese Breast Cancers
NCT02886845 is registered in ClinicalTrials.gov with Song Hongping as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of Two Single Nucleotide Polymorphisms in Chinese Breast Cancers
- Lead sponsor
- Song Hongping
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 31, 2016
- Completion date
- June 30, 2023
- Enrollment
- 2,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
rs185670819 and rs183489969